National Institute Of Arthritis And Musculoskeletal And Skin Diseases Notice of Meeting, 52142 [2020-18441]
Download as PDF
<![CDATA[
52142
Federal Register / Vol. 85, No. 164 / Monday, August 24, 2020 / Notices
Contact Person listed on this notice. The
statement should include the name,
address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute Of Arthritis And
Musculoskeletal And Skin Diseases
Notice of Meeting
jbell on DSKJLSW7X2PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Arthritis and
Musculoskeletal and Skin Diseases
Advisory Council.
The meeting will be open to the
public online as indicated below, with
attendance limited to online
participation only. Individuals who
plan to attend and need special
assistance, such as sign language
interpretation or other reasonable
accommodations, should notify the
Contact Person listed below in advance
of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Arthritis and
Musculoskeletal and Skin Diseases Advisory
Council.
Date: September 1, 2020.
Open: 10:00 a.m. to 12:45 p.m.
Agenda: To discuss program policies and
issues.
Place: National Institutes of Health,
Bethesda, MD, (Virtual Meeting).
Virtual Access: The meeting will be
videocast and can be accessed from the NIH
Videocast https://videocast.nih.gov. Please
note, the link to the videocast meeting will
be posted within a week of the meeting date.
Any member of the public may submit
written comments no later than 15 days after
the meeting.
Closed: 2:00 p.m.–3:30 p.m.
Agenda: To Review and Evaluate Grant
Applications.
Contact Person: Melinda Nelson, Acting
Director, National Institute of Arthritis and
Musculoskeletal and Skin Diseases, Grants
Management Branch, 45 Center Drive,
Natcher Building, Room 5A49, Bethesda, MD
20892, (301) 594–3535, mn23z@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.846, Arthritis,
Musculoskeletal and Skin Diseases Research,
National Institutes of Health, HHS)
Any interested person may file
written comments with the committee
by forwarding the statement to the
VerDate Sep<11>2014
16:31 Aug 21, 2020
Jkt 250001
Dated: August 18, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–18441 Filed 8–21–20; 8:45 am]
BILLING CODE 4140–01–P
National Institutes of Health
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel Small
Business: Low Vision, Ocular Biomedical
and Bioengineering Technology
Development.
Date: September 14, 2020.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Susan Gillmor, Ph.D.,
Scientific Review Officer, National Institutes
of Health, Center for Scientific Review, 6701
Rockledge Drive, Bethesda, MD 20892, (240)
762–3076, susan.gillmor@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel NIH
Research Enhancement Award (R15) in
Oncological Sciences.
Date: September 16, 2020.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Svetlana Kotliarova, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6214,
Bethesda, MD 20892, (301) 594–7945,
kotliars@mail.nih.gov.
Fmt 4703
[FR Doc. 2020–18439 Filed 8–21–20; 8:45 am]
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center For Scientific Review Notice of
Closed Meetings
Frm 00058
Dated: August 18, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
PO 00000
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
National Heart, Lung, and Blood
Institute; Notice of Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Heart, Lung,
and Blood Advisory Council.
The meeting will be open to the
public as indicated below and held as
a virtual meeting. Individuals who plan
to view the virtual meeting and need
special assistance or other reasonable
accommodations to view the meeting,
should notify the Contact Person listed
below in advance of the meeting.
Name of Committee: National Heart, Lung,
and Blood Advisory Council.
Date: September 15, 2020.
Open: 8:00 a.m. to 11:00 a.m.
Agenda: To discuss program policies and
issues.
Place: National Institutes of Health,
Rockledge I, 6705 Rockledge Drive, Room
206–Q, Bethesda, MD 20892, (Virtual
Meeting).
Open: 1:30 p.m. to 4:00 p.m.
Agenda: To discuss program policies and
issues.
Place: National Institutes of Health,
Rockledge I, 6705 Rockledge Drive, Room
206–Q, Bethesda, MD 20892, (Virtual
Meeting).
Virtual Access: The meeting will be
videocast and can be accessed from the NIH
Videocast. Please note, the link to the
videocast meeting will be posted within a
week of the meeting date on the NHLBI
Council website: https://www.nhlbi.nih.gov/
about/advisory-and-peer-review-committees/
advisory-council.
Contact Person: Laura K. Moen, Ph.D.,
Director, Division of Extramural Research
Activities, National Heart, Lung, and Blood
Institute, National Institutes of Health,
Rockledge I, 6705 Rockledge Drive, Bethesda,
MD 20892, 301–435–0260, moenl@
mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
E:\FR\FM\24AUN1.SGM
24AUN1
]]>Agencies
[Federal Register Volume 85, Number 164 (Monday, August 24, 2020)]
[Notices]
[Page 52142]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-18441]
[[Page 52142]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute Of Arthritis And Musculoskeletal And Skin
Diseases Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the National Arthritis
and Musculoskeletal and Skin Diseases Advisory Council.
The meeting will be open to the public online as indicated below,
with attendance limited to online participation only. Individuals who
plan to attend and need special assistance, such as sign language
interpretation or other reasonable accommodations, should notify the
Contact Person listed below in advance of the meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Arthritis and Musculoskeletal and
Skin Diseases Advisory Council.
Date: September 1, 2020.
Open: 10:00 a.m. to 12:45 p.m.
Agenda: To discuss program policies and issues.
Place: National Institutes of Health, Bethesda, MD, (Virtual
Meeting).
Virtual Access: The meeting will be videocast and can be
accessed from the NIH Videocast https://videocast.nih.gov. Please
note, the link to the videocast meeting will be posted within a week
of the meeting date. Any member of the public may submit written
comments no later than 15 days after the meeting.
Closed: 2:00 p.m.-3:30 p.m.
Agenda: To Review and Evaluate Grant Applications.
Contact Person: Melinda Nelson, Acting Director, National
Institute of Arthritis and Musculoskeletal and Skin Diseases, Grants
Management Branch, 45 Center Drive, Natcher Building, Room 5A49,
Bethesda, MD 20892, (301) 594-3535, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.846,
Arthritis, Musculoskeletal and Skin Diseases Research, National
Institutes of Health, HHS)
Any interested person may file written comments with the committee
by forwarding the statement to the Contact Person listed on this
notice. The statement should include the name, address, telephone
number and when applicable, the business or professional affiliation of
the interested person.
Dated: August 18, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-18441 Filed 8-21-20; 8:45 am]
BILLING CODE 4140-01-P
